CellCept (Mycofenolate mofetil)

CellCept (Mycophenolate Mofetil) – Patient Information for Australia

Basic Product Information

What is CellCept?

CellCept is an immunosuppressant medication used to prevent rejection of transplanted organs such as kidneys, hearts, and livers. Its active substance, mycophenolate mofetil, is available in several brands and formulations in Australia. CellCept works by reducing the activity of your immune system so your body is less likely to attack the transplanted organ.

How CellCept Works (Mechanism of Action)

• For patients: CellCept “dampens” the immune response by preventing white blood cells from attacking the new organ. This helps your transplanted organ survive and function properly.
• For specialists: Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase (IMPDH), blocking de novo synthesis of guanosine nucleotides in T and B lymphocytes. This significantly limits lymphocyte proliferation and the immune response underlying transplant rejection.

Pharmacokinetics (How the Medicine Behaves in the Body)

• Absorption: Rapidly absorbed as mycophenolate mofetil; then converted to active mycophenolic acid (MPA).
• Metabolism: Extensively metabolised in the liver, mainly to inactive MPA-glucuronide.
• Elimination: Eliminated primarily via the kidneys (renal excretion) as metabolites.
• Half-life: Approximately 16–18 hours for MPA allows for twice-daily dosing.
• Onset & Duration: Onset within hours; consistent immunosuppressive effect with regular dosing.

Use in Everyday Life and Best Practices

CellCept is typically used as part of combination therapy with other immunosuppressants, such as corticosteroids and calcineurin inhibitors (like tacrolimus or cyclosporine). It is usually prescribed following organ transplantation. Common recommendations include:

• Take CellCept exactly as prescribed by your doctor, even if you feel well.
• Do not stop or adjust your dose without medical advice.
• Be punctual with doses—set reminders if needed.
• Attend all scheduled medical and blood test appointments for monitoring.

Tablets and capsules should be swallowed whole with a glass of water. The oral suspension (liquid) should be prepared and administered according to your healthcare provider's instructions.

Dosing: Morning vs Evening

• Standard dosing: CellCept is taken twice daily, usually in the morning and evening, approximately 12 hours apart.
• Tip: Choose regular meal times for better adherence. Taking doses at the same time every day helps maintain even levels of medication in your blood.
• Advantage of regular timing: Improves effectiveness and safety. Skipping or delaying doses may increase risk of rejection or side effects.

Taking with Food or on an Empty Stomach

• Food Recommendations: CellCept can be taken with or without food. Taking it with food may reduce stomach upset, which is a common side effect.
• Important Note: If you decide to take it with food, try to take every dose the same way (with or without food), to keep your medication levels stable.
• Typical Australian Diet Tips: Avoid taking with dairy products (like milk or yoghurt) if you experience stomach upset. Keep your fluid intake normal and maintain a balanced diet.

Interaction Warnings

Indications for Use

Dosing According to Clinical Indications

Safety Profile and Side Effects

Like all medications, CellCept may cause side effects. Tell your doctor or pharmacist if you notice anything unusual.

• Females of childbearing age: Effective contraception is essential during and for 6 weeks after stopping CellCept. CellCept can cause birth defects and miscarriage.
• Immunosuppression increases infection and cancer risk; report any fever, unusual bruising, lumps, or persistent sore throat promptly.
• Seek medical care urgently for sudden vision changes, confusion, or seizures.

Guidelines for Proper Use

• Have your prescription reviewed and dispensed only at registered Australian pharmacies.
• Wear a medical alert ID indicating you are immunosuppressed.
• Avoid live vaccines (measles, mumps, BCG, yellow fever, etc.), and consult your specialist before travel vaccines.
• Use sunscreen daily (SPF 30+); wear hats and long sleeves outdoors due to increased skin cancer risk.
• Report any sign of infection, bleeding, or severe gastrointestinal symptoms immediately.
• Do not share your medicine with anyone.
• Travelling? Take enough medication and keep it in its original labelled packaging.

Alternative Treatment Options (PBS-reimbursed medicines in Australia)

• Azathioprine (Imuran®): Cheaper and widely available; increased risk of certain side effects; sometimes less effective for some patients.
• Ciclosporin (Neoral®): Effective, but causes hypertension and kidney toxicity long term.
• Tacrolimus (Prograf®, Advagraf®): Often co-prescribed; risk of nephrotoxicity and diabetes.
• Sirolimus (Rapamune®): Used when intolerance to other immunosuppressants; potential for high cholesterol and mouth ulcers.
• Discuss with your transplant or specialist team which alternative is right for you, based on your specific needs and response.

Legal, Registration, and Reimbursement Status in Australia

• Registered with the Therapeutic Goods Administration (TGA Australia) as a prescription medication for transplant patients.
• Listed on the Pharmaceutical Benefits Scheme (PBS) for post-transplant immunosuppression; certain off-label uses are not PBS-subsided.
• Restricted benefit: Only available via authority prescription by specialists (nephrologists, transplant physicians, etc.).
• Legal supply requires valid prescription; not for over-the-counter use.

Latest Research and Clinical Guidance (2022–2025)

• Recent reviews (Australian Prescriber 2023; Transplantation Reviews 2022) confirm CellCept’s status as a first-line immunosuppressant in kidney, heart, and liver transplantation. Dose adjustments may be needed for side effects or in elderly/paediatric patients.
• Long-term registry data suggest a lower rate of chronic rejection and better graft survival when using mycophenolate-based regimens compared to azathioprine.
• Recommendations from the Kidney Health Australia – Caring for Australasians with Renal Impairment (KHA-CARI) guidelines (2023) recommend regular monitoring of immune suppression levels, full blood counts, and renal function in all patients.
• Pandemic advice: Extra vigilance for early symptoms of COVID-19 and other infections in immunosuppressed patients. Consult your specialist before any change to your treatment plan.

Availability and Delivery

*Prices are indicative for PBS-approved uses as of 2024. Actual out-of-pocket costs may vary by pharmacy and individual entitlements.

Frequently Asked Questions (FAQ)

1. What should I do if I miss a dose of CellCept?
   Take the missed dose as soon as you remember. If it’s nearly time for your next dose, skip the missed dose—do not double dose. Always inform your doctor if you miss more than one dose.
2. Can I get a repeat prescription at any pharmacy?
   Yes, with a valid script. However, repeats must be coordinated with your doctor or transplant team to allow for necessary monitoring.
3. Is it safe to get vaccinated on CellCept?
   Only with inactivated (dead) vaccines. Never have live vaccines unless directed by your specialist. Discuss all vaccines, including the flu and COVID-19 shots, with your doctor.
4. Can I become pregnant or father a child while on CellCept?
   CellCept can cause birth defects. Women must use effective contraception and avoid pregnancy while on CellCept and for 6 weeks after stopping. Men should use contraception during and for at least 90 days after treatment.
5. What common side effects should I watch for?
   Stomach upset, diarrhoea, and increased risk of infection are the most common. Any fever, persistent stomach pain, or unexplained bruising should be reported to your doctor promptly.